Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 03-Jul-24 5:16 PM View:  | MacCecchini Maria-Luisa President and CEO Director 10% Owner | Annovis Bio, Inc. (ANVS) | 31-Mar-24 | Gift | 20,000 | -- | -- | (2%) 1.09M to 1.07M | |
| 03-Jul-24 5:16 PM View: | MacCecchini Maria-Luisa President and CEO Director 10% Owner | Annovis Bio, Inc. (ANVS) | 28-Mar-24 | Gift | 10,000 | -- | -- | (< 1%) 1.1M to 1.09M | |
| 21-Nov-23 2:27 PM View: | Bruck Claudine Director | Annovis Bio, Inc. (ANVS) | 20-Nov-23 | Grant | 1,000 | $6.07 | $6,070.00 | 15% 6.57K to 7.57K | |
| 21-Nov-23 2:31 PM View: | White Mark K. Director | Annovis Bio, Inc. (ANVS) | 20-Nov-23 | Grant | 2,000 | $6.07 | $12,140.00 | 3% 59.18K to 61.18K | |
| 21-Nov-23 2:29 PM View: | Hagopian Henry III Chief Financial Officer | Annovis Bio, Inc. (ANVS) | 20-Nov-23 | Grant | 824 | $6.07 | $5,001.68 | 82% 1.0K to 1.82K | |
| 21-Nov-23 2:32 PM View: | Hoffman Michael B Director 10% Owner | Annovis Bio, Inc. (ANVS) | 20-Nov-23 | Grant | 164,745 | $6.07 | $1,000,000.00 | 11% 1.48M to 1.64M | |
| 21-Nov-23 2:33 PM View: | McCarthy Reid Director | Annovis Bio, Inc. (ANVS) | 20-Nov-23 | Grant | 824 | $6.07 | $5,001.68 | 11% 7.3K to 8.13K | |
| 21-Nov-23 2:30 PM View: | MacCecchini Maria-Luisa President and CEO Director 10% Owner | Annovis Bio, Inc. (ANVS) | 20-Nov-23 | Grant | 41,186 | $6.07 | $249,999.00 | 4% 1.06M to 1.1M | |
| 26-Apr-23 4:34 PM View: | MacCecchini Maria-Luisa President and CEO Director 10% Owner | Annovis Bio, Inc. (ANVS) | 24-Apr-23 | Gift | 3,000 | -- | -- | (< 1%) 1.06M to 1.06M | |
| 11-Apr-23 9:14 PM View: | White Mark K. Director | Annovis Bio, Inc. (ANVS) | 07-Apr-23 | Grant | 3,000 | $12.61 | $37,830.00 | 5% 56.18K to 59.18K | |
| 11-Apr-23 9:08 PM View: | Hagopian Henry III Chief Financial Officer | Annovis Bio, Inc. (ANVS) | 07-Apr-23 | Grant | 1,000 | $12.61 | $12,610.00 | 100% 0 to 1.0K | |
| 11-Apr-23 9:06 PM View: | Hoffman Michael B Director 10% Owner | Annovis Bio, Inc. (ANVS) | 07-Apr-23 | Grant | 59,477 | $12.61 | $750,005.00 | 4% 1.42M to 1.48M | |
| 11-Apr-23 9:05 PM View: | McCarthy Reid Director | Annovis Bio, Inc. (ANVS) | 07-Apr-23 | Grant | 476 | $12.61 | $6,002.36 | 7% 6.83K to 7.3K | |
| 11-Apr-23 9:11 PM View: | Bruck Claudine Director | Annovis Bio, Inc. (ANVS) | 07-Apr-23 | Grant | 500 | $12.61 | $6,305.00 | 8% 6.07K to 6.57K | |
| 11-Apr-23 9:03 PM View: | MacCecchini Maria-Luisa President and CEO Director 10% Owner | Annovis Bio, Inc. (ANVS) | 07-Apr-23 | Grant | 20,000 | $12.61 | $252,200.00 | 2% 1.04M to 1.06M | |
| 08-Feb-23 5:11 PM View: | MacCecchini Maria-Luisa President and CEO Director 10% Owner | Annovis Bio, Inc. (ANVS) | 06-Feb-23 | Option Exercise | 52,755 | $0.14 | $7,385.70 | 5% 987.74K to 1.04M | |
| 18-Jan-22 9:08 PM View: | MacCecchini Maria-Luisa President and CEO Director 10% Owner | Annovis Bio, Inc. (ANVS) | 14-Jan-22 | Option Exercise | 32,959 | $0.14 | $4,614.26 | 3% 954.77K to 987.73K | |
| 05-Jan-22 7:41 PM View: | Hoffman Michael B Director 10% Owner | Annovis Bio, Inc. (ANVS) | 04-Jan-22 | Payment of Exercise | 6,748 | $19.78 | $133,475.00 | (< 1%) 1.42M to 1.42M | |
| 05-Jan-22 7:41 PM View: | Hoffman Michael B Director 10% Owner | Annovis Bio, Inc. (ANVS) | 04-Jan-22 | Option Exercise | 37,142 | $3.59 | $133,486.00 | 3% 1.39M to 1.42M | |
| 18-Jan-22 10:00 PM View: | MacCecchini Maria-Luisa President and CEO Director 10% Owner | Annovis Bio, Inc. (ANVS) | 20-Dec-21 | Gift | 20,000 | -- | -- | (2%) 974.77K to 954.77K | |
| 13-Oct-21 4:02 PM View: | White Mark K. Director | Annovis Bio, Inc. (ANVS) | 12-Oct-21 | Market Purchase | 5,000 | $27.40 | $137,000.00 | 10% 51.18K to 56.18K | |
| 13-Oct-21 4:03 PM View: | Bruck Claudine Director | Annovis Bio, Inc. (ANVS) | 11-Oct-21 | Market Purchase | 181 | $27.66 | $5,006.46 | 3% 5.89K to 6.07K | |
| 13-Oct-21 4:00 PM View: | MacCecchini Maria-Luisa President and CEO Director 10% Owner | Annovis Bio, Inc. (ANVS) | 11-Oct-21 | Market Purchase | 18,000 | $27.61 | $496,980.00 | 2% 958.77K to 976.77K | |
| 23-Aug-21 11:36 AM View: | McCarthy Reid Director | Annovis Bio, Inc. (ANVS) | 19-Aug-21 | Market Purchase | 500 | $37.61 | $18,805.00 | 8% 6.33K to 6.83K | (2%) |
| 18-Jan-22 10:00 PM View: | MacCecchini Maria-Luisa President and CEO Director 10% Owner | Annovis Bio, Inc. (ANVS) | 01-Jul-21 | Gift | 2,000 | -- | -- | (< 1%) 976.77K to 974.77K | |
| 18-Jan-22 10:00 PM View: | MacCecchini Maria-Luisa President and CEO Director 10% Owner | Annovis Bio, Inc. (ANVS) | 15-Jul-20 | Gift | 10,000 | -- | -- | (1%) 986.77K to 976.77K | |
| 18-Jan-22 10:00 PM View: | MacCecchini Maria-Luisa President and CEO Director 10% Owner | Annovis Bio, Inc. (ANVS) | 27-Apr-20 | Gift | 10,000 | -- | -- | (1%) 996.77K to 986.77K | |
| 05-Feb-20 6:03 AM View: | McGroarty Jeffrey B Chief Financial Officer | Annovis Bio, Inc. (ANVS) | 03-Feb-20 | Purchase | 19,500 | $7.15 | $139,428.00 | 59% 33.33K to 52.83K | |
| 05-Feb-20 6:05 AM View: | Hoffman Michael B Director 10% Owner | Annovis Bio, Inc. (ANVS) | 31-Jan-20 | Conversion | 1,352,560 | $0.20 | $268,243.00 | 9468% 14.28K to 1.37M | |
| 05-Feb-20 6:05 AM View: | Hoffman Michael B Director 10% Owner | Annovis Bio, Inc. (ANVS) | 31-Jan-20 | Purchase | 33,333 | $6.00 | $199,998.00 | 2% 1.37M to 1.4M | |
| 05-Feb-20 6:02 AM View: | White Mark K. Director | Annovis Bio, Inc. (ANVS) | 31-Jan-20 | Conversion | 49,443 | $0.32 | $15,609.60 | 100% 0 to 49.44K | |
| 05-Feb-20 6:04 AM View: | Bruck Claudine Director | Annovis Bio, Inc. (ANVS) | 31-Jan-20 | Purchase | 800 | $6.00 | $4,800.00 | 16% 5.09K to 5.89K | |
| 05-Feb-20 6:03 AM View: | MacCecchini Maria-Luisa President and CEO Director 10% Owner | Annovis Bio, Inc. (ANVS) | 31-Jan-20 | Conversion | 770,833 | -- | -- | 374% 206.34K to 977.17K | |
| 05-Feb-20 6:03 AM View: | MacCecchini Maria-Luisa President and CEO Director 10% Owner | Annovis Bio, Inc. (ANVS) | 31-Jan-20 | Purchase | 1,600 | $6.00 | $9,600.00 | < 1% 977.17K to 978.77K | |
| 05-Feb-20 6:05 AM View: | Whelan, Jr. Robert M. Director | Annovis Bio, Inc. (ANVS) | 31-Jan-20 | Conversion | 70,700 | $0.76 | $53,644.80 | 100% 0 to 70.7K | |
| 05-Feb-20 6:02 AM View: | White Mark K. Director | Annovis Bio, Inc. (ANVS) | 31-Jan-20 | Purchase | 1,734 | $6.00 | $10,404.00 | 4% 49.44K to 51.18K | |
| 05-Feb-20 6:03 AM View: | McGroarty Jeffrey B Chief Financial Officer | Annovis Bio, Inc. (ANVS) | 31-Jan-20 | Purchase | 33,333 | $6.00 | $199,998.00 | 100% 0 to 33.33K | |
| 05-Feb-20 6:05 AM View: | Whelan, Jr. Robert M. Director | Annovis Bio, Inc. (ANVS) | 31-Jan-20 | Purchase | 25,000 | $6.00 | $150,000.00 | 35% 70.7K to 95.7K | |
| 05-Feb-20 6:04 AM View: | Bruck Claudine Director | Annovis Bio, Inc. (ANVS) | 31-Jan-20 | Conversion | 5,086 | $1.05 | $5,361.60 | 100% 0 to 5.09K |
